Archive: October 2014

Platinum Agents in the Treatment of Early-Stage Triple-Negative Breast Cancer: Is It Time to Change Practice?

Laila Saied Agrawal, MD, and Ingrid A. Mayer, MD, MSCI

Clinical Advances in Hematology & Oncology October 2014, Volume 12, Issue 10   Laila Saied Agrawal, MD, and Ingrid A. Mayer, MD, MSCI The authors are […]

Update on the Chemotherapeutic Management of Endometrial Cancer

Amy Bregar, MD, Katina Robison, MD, and Don S. Dizon, MD

Clinical Advances in Hematology & Oncology October 2014, Volume 12, Issue 10 Amy Bregar, MD, Katina Robison, MD, and Don S. Dizon, MD Dr Bregar is […]

Practical Recommendations on Incorporating New Oral Anticoagulants Into Routine Practice

Jaskirat Randhawa, MD, Nirosshan Thiruchelvam, MD, Michael Ghobrial, MD, Timothy Spiro, MD, Bernadette Clark, PharmD, Abdo Haddad, MD, and Hamed Daw, MD

Clinical Advances in Hematology & Oncology October 2014, Volume 12, Issue 10 Jaskirat Randhawa, MD, Nirosshan Thiruchelvam, MD, Michael Ghobrial, MD, Timothy Spiro, MD, Bernadette Clark, […]

Should Lung Cancer Screening With Low-Dose Computed Tomography Be Routine for Smokers and Former Smokers?

Devon Schuyler

Clinical Advances in Hematology & Oncology October 2014, Volume 12, Issue 10 The U.S. Preventive Services Task Force (USPSTF) gave a grade of B to low-dose […]

The Promise of Liquid Biopsy in Colorectal Cancer

Clinical Advances in Hematology & Oncology October 2014, Volume 12, Issue 10   Luis Alberto Diaz, MD Associate Professor of Oncology, The Johns Hopkins University School of […]

The Red Cell Membrane, Part 3: The Role of the Red Cell Membrane in Coagulation and Hypercoagulability

Clinical Advances in Hematology & Oncology October 2014, Volume 12, Issue 10   Bas De Laat, PhD Associate Professor, Department of Biochemistry, Maastricht University, Maastricht, the Netherlands This is […]

Unleashing the Power of Preemptive Pharmacogenomics

Clinical Advances in Hematology & Oncology October 2014, Volume 12, Issue 10 Peter H. O’Donnell, MD Assistant Professor of Medicine, University of Chicago, Chicago, Illinois   H&O  What […]

ABT-199 for Chronic Lymphocytic Leukemia

Clinical Advances in Hematology & Oncology October 2014, Volume 12, Issue 10   John Seymour, MD Professor, Director, Cancer Medicine, Peter MacCallum Cancer Centre, Victoria, Australia   H&O  What […]

Hem/Onc News

Devon Schuyler

Clinical Advances in Hematology & Oncology October 2014, Volume 12, Issue 10 FDA Approves Pembrolizumab for Advanced Melanoma The US Food and Drug Administration (FDA) has […]

Letter From the Editor

Clinical Advances in Hematology & Oncology October 2014, Volume 12, Issue 10 The Interviewing of the Fellows The interview season has begun once again. Prospective fellows […]

Back to Archive